Cowen Starts Sage Therapeutics (SAGE) at Outperform
Tweet Send to a Friend
Cowen initiates coverage on Sage Therapeutics (NASDAQ: SAGE) with a Outperform rating and a price target of $95.00.Analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE